First Time Loading...
W

Walvax Biotechnology Co Ltd
SZSE:300142

Watchlist Manager
Walvax Biotechnology Co Ltd
SZSE:300142
Watchlist
Price: 15.12 CNY 0.2% Market Closed
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one Walvax Biotechnology Co Ltd stock under the Base Case scenario is 35.5 CNY. Compared to the current market price of 15.12 CNY, Walvax Biotechnology Co Ltd is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
35.5 CNY
Undervaluation 57%
Relative Value
Price
W
Worst Case
Base Case
Best Case

Valuation Multiples

5.9
P/S
P/S
Price to Sales
5.9
vs History
96
vs Industry
62
Median 3Y
12.8
Median 5Y
23.4
Industry
8.3
Forward
4.8
More Details
57.7
P/E
P/E
Price to Earnings
57.7
vs History
73
vs Industry
3
Median 3Y
89.7
Median 5Y
89.7
Industry
26.8
Forward
25.4
More Details
21.3
P/OCF
P/OCF
Price to OCF
21.3
vs History
87
vs Industry
8
Median 3Y
53.5
Median 5Y
100
Industry
23.3
More Details
37.9
P/FCFE
P/FCFE
Price to FCFE
37.9
vs History
34
vs Industry
5
Median 3Y
46.5
Median 5Y
-146.8
Industry
21.4
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
96
vs Industry
37
Median 3Y
7.3
Median 5Y
8.9
Industry
2.6
More Details
5
EV/S
EV/S
Enterprise Value to Sales
5
vs History
96
vs Industry
55
Median 3Y
12.2
Median 5Y
22.4
Industry
7.5
Forward
4.1
More Details
6.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.1
vs History
96
vs Industry
53
Median 3Y
13.8
Median 5Y
25.6
Industry
9.2
More Details
26.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
26.7
vs History
96
vs Industry
5
Median 3Y
49.8
Median 5Y
78.5
Industry
4.5
Forward
13.5
More Details
26.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.7
vs History
96
vs Industry
5
Median 3Y
49.8
Median 5Y
78.5
Industry
4.4
Forward
15.5
More Details
18.2
EV/OCF
EV/OCF
Enterprise Value to OCF
18.2
vs History
87
vs Industry
9
Median 3Y
50.7
Median 5Y
95.9
Industry
5.6
More Details
109.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
109.6
vs History
30
vs Industry
2
Median 3Y
106.1
Median 5Y
-148.8
Industry
3.4
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
96
vs Industry
48
Median 3Y
6.3
Median 5Y
8.8
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Walvax Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Walvax Biotechnology Co Ltd
SZSE:300142
24.2B CNY 5.9 57.7 26.7 26.7
US
Abbvie Inc
NYSE:ABBV
282.8B USD 5.2 58.7 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
163.1B USD 5.5 43.4 18.4 30.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
108.8B USD 11 30 24.2 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
105.5B USD 8.1 27.3 22.1 24.5
AU
CSL Ltd
ASX:CSL
135.1B AUD 6.3 36 21.8 27
US
Gilead Sciences Inc
NASDAQ:GILD
81B USD 3 167.4 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
46.5B USD 9 -7.8 -8.5 -7.5
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.1B USD 3.3 27.5 14.1 17.6
KR
Celltrion Inc
KRX:068270
40.3T KRW 18.5 75.3 46 63.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.